Marksans Pharma Ltd (MARKSANS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 604869,
    "name": "Marksans Pharma",
    "stock_name": "Marksans Pharma",
    "full_name": "Marksans Pharma Ltd",
    "name_url": "stocks-analysis/marksans-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "261.00",
    "chg": 6.25,
    "chgp": "2.45%",
    "dir": 1,
    "prev_price": "254.75",
    "mcapval": "12,004.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524404,
    "symbol": "MARKSANS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE750C01026",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "46.45 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/marksans-pharma-604869-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Marksans Pharma Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-marksans-pharma-ltd-3990132",
        "imagepath": "",
        "date": "2026-05-13 23:16:59",
        "description": "The next results date for Marksans Pharma Ltd is scheduled for 26 May 2026...."
      },
      {
        "title": "Marksans Pharma Ltd Shows Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-shows-technical-momentum-shift-amid-mixed-market-signals-3986469",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MarksansPharmaL_technicaldot_3986469.png",
        "date": "2026-05-12 08:04:26",
        "description": "Marksans Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across various timeframes. This development comes alongside a recent upgrade in its Mojo Grade from Sell to Hold, signalling cautious optimism among market analysts."
      },
      {
        "title": "Marksans Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-ltd-is-rated-sell-3983956",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MarksansPharmaL_mojoScore_3983956.png",
        "date": "2026-05-10 10:10:37",
        "description": "Marksans Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 28 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Marksans Pharma Ltd Surges 8.77% to Day's High of Rs 203.45 — Outperforms Sector by 6.99 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-hits-intraday-high-with-strong-877-surge-3977816",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MarksansPharmaL_priceRelatedfactors_3977816.png",
        "date": "2026-05-06 11:16:02",
        "description": "The Sensex edged up a modest 0.17% on 6 May 2026, while Marksans Pharma Ltd surged 8.77%, touching an intraday high of Rs 203.45. This 6.99-percentage-point outperformance over the Pharmaceuticals & Biotechnology sector signals a distinctly stock-specific rally rather than a broad market lift."
      },
      {
        "title": "Marksans Pharma Ltd Valuation Shifts Signal Price Attractiveness Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-valuation-shifts-signal-price-attractiveness-challenges-3969345",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MarksansPharmaL_valuationdot_3969345.png",
        "date": "2026-04-30 08:00:28",
        "description": "Marksans Pharma Ltd has seen a notable shift in its valuation parameters, moving from fair to expensive territory, reflecting a change in price attractiveness amid evolving market dynamics. This article analyses the recent valuation changes, compares them with peer averages and historical benchmarks, and assesses the implications for investors."
      },
      {
        "title": "Marksans Pharma Gains 5.96%: 4 Key Factors Driving the Weekly Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-gains-596-4-key-factors-driving-the-weekly-rally-3962691",
        "imagepath": "",
        "date": "2026-04-25 16:08:52",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Apr:</strong> Stock opens at Rs.176.85, down 1.50% amid flat Sensex</p>\n                    <p><strong>22 Apr:</strong> Price rebounds with 1.53% gain to Rs.179.60</p>\n                    <p><strong>23 Apr:</strong> Intraday high of Rs.193.55 with 7.04% surge; strong volume spike</p>\n                    <p><strong>24 Apr:</strong> MarketsMOJO upgrades rating to Hold; valuation shifts to expensive</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.179.55</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div cl..."
      },
      {
        "title": "Marksans Pharma Ltd Upgraded to Hold by MarketsMOJO on Improving Technicals and Stable Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-ltd-upgraded-to-hold-by-marketsmojo-on-improving-technicals-and-stable-financials-3960229",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MarksansPharmaL_mojoScore_3960229.png",
        "date": "2026-04-24 08:10:39",
        "description": "Marksans Pharma Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced shift in its technical outlook and valuation metrics. Despite flat recent financial performance, improvements in technical indicators and a reassessment of valuation have prompted this change, signalling cautious optimism for investors in this small-cap pharmaceutical player."
      },
      {
        "title": "Marksans Pharma Ltd Shares Gain Momentum Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-shares-gain-momentum-amid-mixed-technical-signals-3960080",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MarksansPharmaL_technicaldot_3960080.png",
        "date": "2026-04-24 08:01:36",
        "description": "Marksans Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. The stock’s recent 7.49% surge to ₹193.05, following a previous close of ₹179.60, underscores renewed investor interest amid mixed monthly and weekly technical readings."
      },
      {
        "title": "Marksans Pharma Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-valuation-shifts-signal-changing-market-sentiment-3960012",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MarksansPharmaL_valuationdot_3960012.png",
        "date": "2026-04-24 08:00:25",
        "description": "Marksans Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, reflecting evolving market perceptions and price attractiveness. This article analyses the recent changes in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, comparing them with historical trends and peer benchmarks to provide a comprehensive view of the stock’s current standing."
      }
    ],
    "total": 15,
    "sid": "604869",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/marksans-pharma-604869"
  },
  "announcements": [
    {
      "caption": "Announcement Under Regulation 30 (LODR)- Updates",
      "datetime": "16-Jun-2026",
      "details": "Update on acquisition of QliniQ B.V.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "09-Jun-2026",
      "details": "India Ratings and Research has revised the outlook for the Companys bank loan facilities to Positive from Stable",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "08-Jun-2026",
      "details": "Intimation of schedule for Virtual Investors Conference",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Marksans Pharma Ltd has declared <strong>80%</strong> dividend, ex-date: 01 Aug 25",
          "dt": "2025-08-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Marksans Pharma Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Mar 08",
          "dt": "2008-03-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

When is the next results date for Marksans Pharma Ltd?

2026-05-13 23:16:59

The next results date for Marksans Pharma Ltd is scheduled for 26 May 2026....

Marksans Pharma Ltd Shows Technical Momentum Shift Amid Mixed Market Signals

2026-05-12 08:04:26

Marksans Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across various timeframes. This development comes alongside a recent upgrade in its Mojo Grade from Sell to Hold, signalling cautious optimism among market analysts.

Marksans Pharma Ltd is Rated Sell

2026-05-10 10:10:37

Marksans Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 28 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Marksans Pharma Ltd Surges 8.77% to Day's High of Rs 203.45 — Outperforms Sector by 6.99 Percentage Points

2026-05-06 11:16:02

The Sensex edged up a modest 0.17% on 6 May 2026, while Marksans Pharma Ltd surged 8.77%, touching an intraday high of Rs 203.45. This 6.99-percentage-point outperformance over the Pharmaceuticals & Biotechnology sector signals a distinctly stock-specific rally rather than a broad market lift.

Marksans Pharma Ltd Valuation Shifts Signal Price Attractiveness Challenges

2026-04-30 08:00:28

Marksans Pharma Ltd has seen a notable shift in its valuation parameters, moving from fair to expensive territory, reflecting a change in price attractiveness amid evolving market dynamics. This article analyses the recent valuation changes, compares them with peer averages and historical benchmarks, and assesses the implications for investors.

Marksans Pharma Gains 5.96%: 4 Key Factors Driving the Weekly Rally

2026-04-25 16:08:52

Key Events This Week 20 Apr: Stock opens at Rs.176.85, down 1.50% amid flat Sensex 22 Apr: Price rebounds with 1.53% gain to Rs.179.60 23 Apr: Intraday high of Rs.193.55 with 7.04% surge; strong volume spike 24 Apr: MarketsMOJO upgrades rating to Hold; valuation shifts to expensive Week OpenRs.179.55 Week Close<div cl...

Marksans Pharma Ltd Upgraded to Hold by MarketsMOJO on Improving Technicals and Stable Financials

2026-04-24 08:10:39

Marksans Pharma Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced shift in its technical outlook and valuation metrics. Despite flat recent financial performance, improvements in technical indicators and a reassessment of valuation have prompted this change, signalling cautious optimism for investors in this small-cap pharmaceutical player.

Marksans Pharma Ltd Shares Gain Momentum Amid Mixed Technical Signals

2026-04-24 08:01:36

Marksans Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. The stock’s recent 7.49% surge to ₹193.05, following a previous close of ₹179.60, underscores renewed investor interest amid mixed monthly and weekly technical readings.

Marksans Pharma Ltd Valuation Shifts Signal Changing Market Sentiment

2026-04-24 08:00:25

Marksans Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, reflecting evolving market perceptions and price attractiveness. This article analyses the recent changes in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, comparing them with historical trends and peer benchmarks to provide a comprehensive view of the stock’s current standing.

View All News